Sale!

FGFR2 Gene Apert Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR2 Gene Apert Syndrome Genetic Test is a specialized diagnostic examination designed to identify mutations in the FGFR2 gene, which are responsible for Apert Syndrome. Apert Syndrome is a genetic disorder characterized by the premature fusion of certain skull bones, leading to abnormalities in the shape of the head and face. It also affects the hands and feet, often resulting in webbed or fused fingers and toes.

This test is crucial for early detection and management of the condition, allowing healthcare providers to offer appropriate treatment and interventions to improve the quality of life for affected individuals. The procedure involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the FGFR2 gene.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the FGFR2 Gene Apert Syndrome Genetic Test is available for 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable results. This test is a valuable resource for families with a history of Apert Syndrome or for individuals exhibiting symptoms related to the condition, providing them with essential information for making informed decisions about their health and future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGFR2 Gene Apert Syndrome Genetic Test

Components:

  • Test Name: FGFR2 Gene Apert syndrome Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for FGFR2 Gene Apert syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Apert syndrome NGS Genetic DNA Test gene FGFR2.

Test Details:

The FGFR2 gene is associated with a rare genetic disorder called Apert syndrome. Apert syndrome is characterized by craniosynostosis, which is the premature fusion of certain skull bones, leading to abnormal head shape and facial features. It also affects the hands and feet, causing fusion of certain fingers and toes.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the FGFR2 gene for mutations or variations that may be associated with Apert syndrome. This type of genetic testing allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive assessment of genetic variants.

NGS genetic testing for Apert syndrome can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling and family planning. It is typically performed on a blood or saliva sample and involves sequencing the DNA to identify any genetic changes in the FGFR2 gene.

It is important to note that genetic testing for Apert syndrome should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.

Test Name FGFR2 Gene Apert syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGFR2 Gene Apert syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Apert syndrome NGS Genetic DNA Test gene FGFR2
Test Details

The FGFR2 gene is associated with a rare genetic disorder called Apert syndrome. Apert syndrome is characterized by craniosynostosis, which is the premature fusion of certain skull bones, leading to abnormal head shape and facial features. It also affects the hands and feet, causing fusion of certain fingers and toes.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the FGFR2 gene for mutations or variations that may be associated with Apert syndrome. This type of genetic testing allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive assessment of genetic variants.

NGS genetic testing for Apert syndrome can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling and family planning. It is typically performed on a blood or saliva sample and involves sequencing the DNA to identify any genetic changes in the FGFR2 gene.

It is important to note that genetic testing for Apert syndrome should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.